Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2025 08:30 ET | Source: CLEAR

CLEAR Announces Contract with CMS to Power Secure, Seamless Digital Identity for Medicare.gov

CLEAR enters into a contract with CMS to use CLEAR1 to support identity verification for Medicare beneficiaries and providers on Medicare.gov.
November 06, 2025 09:00 ET | Source: Notified

Notified Boosts News Integrity with CLEAR Identity Verification for GlobeNewswire Press Releases in Canada

CLEAR Verified, the trusted identity verification feature for GlobeNewswire press releases, is now available for Canadian customers.
November 06, 2025 06:00 ET | Source: CLEAR

CLEAR Announces Third Quarter 2025 Financial Results

CLEAR Announces Third Quarter 2025 Financial Results
December 19, 2023 10:24 ET | Source: Landing

UPDATE – Landing Partners with CLEAR to Bring New Level of Security and Convenience to Apartment Rentals

BIRMINGHAM, Ala., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Landing, the company behind the first membership for flexible apartment living, has partnered with CLEAR, the secure identity company, to...
April 19, 2023 10:00 ET | Source: The Clear Cannabis

The Clear Cannabis Announces Expansion into Arkansas Market

DENVER, April 19, 2023 (GLOBE NEWSWIRE) -- Clear Cannabis Inc.™, a national licensor of The Clear™, a legacy cannabis brand of innovative and high quality distilled concentrate products, has...
November 27, 2017 10:00 ET | Source: Zuora, Inc.

Zuora Recognized as a Global Leader in the First IDC MarketScape for Subscription Relationship Management

SAN MATEO, Calif., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Zuora, Inc., the leading SaaS provider of subscription order-to-cash solutions, was named a Leader in the IDC MarketScape: Worldwide Subscription...
October 02, 2017 16:30 ET | Source: Esperion Therapeutics, Inc.

Esperion Completes Patient Enrollment in Global Pivotal Phase 3 Program for Bempedoic Acid

– Pivotal Phase 3 Top-Line Results for Bempedoic Acid Expected in the Second and Third Quarters of 2018 –– NDA Submission for LDL-C Lowering Indication for Bempedoic Acid Planned by First Quarter 2019...
January 04, 2017 17:00 ET | Source: Esperion Therapeutics, Inc.

Esperion to Present at the 35th Annual J.P. Morgan Healthcare Conference

ANN ARBOR, Mich., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on developing and commercializing complementary oral therapies for...
November 09, 2016 16:30 ET | Source: Esperion Therapeutics, Inc.

Esperion Therapeutics to Present at the Stifel 2016 Healthcare Conference

Presentation and Webcast on Wednesday, November 16, 2016 at 3:00 p.m. Eastern Time ANN ARBOR, Mich., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical...
November 03, 2016 16:05 ET | Source: Esperion Therapeutics, Inc.

Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial Results

ANN ARBOR, Mich., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical company focused on developing and commercializing oral therapies for the treatment...